Stifel Financial’s Maravai LifeSciences MRVI Stock Holding History

Stifel Financial’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$39.7K	Buy	14,027 +3,000	+27%	+$10.2K	﹤0.01%	3591
2025 Q4	$35.8K	Buy	+11,027	New	+$37.1K	﹤0.01%	3542
2025 Q3	–	Sell	-11,399	Closed	-$27.5K	–	3603
2025 Q2	$27.5K	Buy	+11,399	New	+$24K	﹤0.01%	3443
2023 Q4	–	Sell	-12,292	Closed	-$123K	–	3388
2023 Q3	$123K	Buy	12,292 +439	+4%	+$4.82K	﹤0.01%	3078
2023 Q2	$147K	Buy	+11,853	New	+$160K	﹤0.01%	3108
2021 Q4	–	Sell	-27,392	Closed	-$1.34M	–	3428
2021 Q3	$1.34M	Sell	27,392 -19,894	-42%	-$970K	﹤0.01%	1861
2021 Q2	$1.97M	Buy	47,286 +35,986	+318%	+$1.39M	﹤0.01%	1622
2021 Q1	$403K	Sell	11,300 -358	-3%	-$11.9K	﹤0.01%	2609
2020 Q4	$327K	Buy	+11,658	New	+$325K	﹤0.01%	2550

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Stifel Financial's MRVI Position: Q1 2026 in Review

Stifel Financial increased its Maravai LifeSciences (MRVI) stake by 27% in Q1 2026, buying an estimated $10.2K and bringing the position to 14,027 shares worth $39.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3591.

Stifel Financial first reported a position in MRVI in Q4 2020 and has held it in 9 quarters since. The position peaked at $1.97M in Q2 2021. 158 funds tracked by Wall St. Rank hold MRVI as of Q1 2026.

Stifel Financial held 14,027 shares of Maravai LifeSciences worth $39.7K as of Q1 2026.
Stifel Financial bought 3,000 Maravai LifeSciences shares in Q1 2026, an estimated $10.2K.
Maravai LifeSciences made up ﹤0.01% of Stifel Financial's portfolio in Q1 2026, its #3591 holding.
Stifel Financial first reported a position in Maravai LifeSciences in Q4 2020 and has held it in 9 quarters since.
Stifel Financial's Maravai LifeSciences position peaked at $1.97M in Q2 2021.
158 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2026.

Based on Stifel Financial's 13F filing for Q1 2026, filed 12 May 2026.